ReviewVeterinary research communications2025
Bridging biology and therapy: translational advances of extracellular vesicles in veterinary clinical practice.
Review in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Seminal Extracellular Vesicles as Molecular Modulators of Male Reproductive Function.Reproduction in domestic animals = Zuchthygiene · 2026Review
- Plant-Derived Nanocarriers for Drug Delivery: A Unified Framework Integrating Extracellular Vesicles, Engineered Phytocarriers, Hybrid Platforms, and Bioinspired Systems.Plants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) are small membrane-bound particles released by numerous cell types and are gaining popularity in veterinary medicine due to their extensive biological activities and therapeutic potential. This review summarizes the classification, biogenesis, and molecular cargo of various types of EVs, such as exosomes, microvesicles, and apoptotic bodies, as well as their emerging roles in cellular communication, diagnostics, and therapeutics across a wide range of veterinary applications. Beyond mesenchymal stem cell (MSC)-derived EVs, EVs from immune cells, pathogens, and body fluids show great promise for tissue healing, immunological regulation, infectious disease management, drug delivery systems, vaccine development, and reproductive health. We critically evaluate recent advancements, limitations, and future possibilities in using EVs to improve diagnosis and treatment results in veterinary species. The review's goal is to provide a comprehensive picture of the rapidly increasing EV landscape and to make it easier to incorporate EV-based technology into clinical veterinary practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.